Adjuvant Capital Impact Investors
Adjuvant Capital is a life sciences investment firm focused on global health.
Industry:
N/A
Technology:
COVID-19 Investors
Funding Status:
N/A
Investment Stage:
Early Stage Venture, Late Stage Venture, Venture
Estimated Revenue:
$1M to $10M
Headquarters:
New York, New York, United States
Employee Number:
1-10
Number Of Exists:
2
Investor Type:
Venture Capital
Total Funding:
N/A
Founded Date:
2012-01-01